UC HEALTH LINE: New 'Individualized' Treatments Tackle Alcohol Dependence
A new generation of approved drugs designed to act on the part of the brain that controls cravings may improve the lives of people struggling with alcohol dependence.
First recognized as a disease 50 years ago, alcoholism has long been treated exclusively through counseling or mutual support groups.
Robert Anthenelli, MD, associate professor in the
at the University of Cincinnati (UC) with an appointment at the Cincinnati Veterans Affairs Medical Center, says that while support and counseling are key components to overcoming alcoholism, oftentimes medication is also needed.
Research on currently approved medications shows that patients are responding to pills that regulate cravings, he says.
The shift toward treatment in the form of a pill, says Dr. Anthenelli, also presents a new opportunity for patient-physician communication.
With these new tools, health-care providers can work with patients to take control of a disease that for a long time seemed impossible to treat in the doctors office, he says.
This new approach was reinforced in July, when the National Institute on Alcohol Abuse and Alcoholism (NIAAA) issued a clinicians guide for caring for patients with heavy drinking and alcohol abuse disorders.
Dr. Anthenelli, director of the Tristate Tobacco and Alcohol Research Center (Tri-TARC), has conducted clinical trials on many of the approved medications on the market today and continues to study novel medications. He is now leading a five-year study to determine how an alcohol-dependent persons genes influence response to medication.
Funded by the NIAAA, the study will attempt to match the elements of a persons individual genetic blueprint with specific medications.
Were making important strides by developing new medications to treat alcoholism, Dr. Anthenelli says, but the next frontier is to try to better personalize therapies based on that individuals genetic profile.
According to the NIAAA, 17.6 million Americans suffer from alcohol dependence or abuse, but in a given year, only 12 percent receive treatment.
With many new treatment options, says Dr. Anthenelli, there should be no reason for patients to suffer from this devastating disease.
Its important to know where to find help for alcohol and other substance abuse, says Dr. Anthenelli. September is National Alcohol and Drug Addiction Recovery Month, so we encourage people to seek out treatment programs for themselves or their loved ones and talk to physicians about new medications.
To learn more about alcohol dependence or current clinical trials at UC, call Tri-TARC at (877)-TRI-TARC(877) 874-8272or (513) 558-7179.
For more information on this and other health-care issues, visit NetWellness at
. A nonprofit health information Web site, NetWellness is provided as a public service by the University of Cincinnati, Case Western Reserve University and Ohio State University.
UC Health Line provides timely health information and is distributed every Tuesday by the UC Academic Health Center Public Relations and Communications Office.
Tags
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.